Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 6/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.36 |
| ▸ | PI4KA | P42356 | 1/20 | 0.33 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.33 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.33 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.31 |
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.31 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.30 |
| ▸ | PDE8B | O95263 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12157547 | 0.78 | ADORA2A (0.39) | ADORA2AADORA1ADORA2BADORA3TLR7 | |
| SCHEMBL731519 | 0.76 | TLR7 (0.41) | TLR7 | |
| SCHEMBL10121602 | 0.76 | ADORA2A (0.42) | ADORA2AADORA1ADORA2BADORA3TLR7 | |
| SCHEMBL1840765 | 0.73 | DHFR (0.38) | — | |
| SCHEMBL12857099 | 0.72 | CYP1A2 (0.38) | ADORA2AADORA1ADORA2BADORA3 | |
| SCHEMBL1146282 | 0.72 | PDE4B (0.34) | ADORA2AADORA1ADORA2BADORA3TLR7 | |
| SCHEMBL10121590 | 0.72 | ADORA3 (0.32) | ADORA2AADORA1ADORA3 | |
| SCHEMBL4551801 | 0.71 | ADORA2A (0.44) | ADORA2AADORA1ADORA2BADORA3TLR7 | |
| SCHEMBL13811523 | 0.70 | — | — | |
| SCHEMBL12157746 | 0.69 | TLR7 (0.40) | TLR7TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8575340-B2 | Purine derivatives and their pharmaceutical uses | GLAXOSMITHKLINE LLC (US) | 2013-11-05 | — | — | US | disclosed |
| US-20120315291-A1 | PURINE DERIVATIVES AND THEIR PHARMACEUTICAL USES | GLAXOSMITHKLINE LLC (US) | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120315291-A1 | PURINE DERIVATIVES AND THEIR PHARMACEUTICAL USES | STING1, IFNG, IRF3 | ADORA2A 48/4885ADORA1 23/4885ADORA2B 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.